A Multi-center, Randomized, Double-blind, Active-controlled, 8-week Study to Evaluate the Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Active-controlled, 8-week Study to Evaluate the Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension
This study assessed the efficacy of LCZ696 in Japanese patients with essential hypertension
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply.
Chikushi-gun, Fukuoka 811-1244, Japan
Ibadraki, Osaka 567-0876, Japan
Hiki-Gun, Saitama 355-0328, Japan
Bunkyo-ku, Tokyo 113-0031, Japan
Bunkyo-ku, Tokyo 113-8655, Japan
Chiyoda-ku, Tokyo 100-0005, Japan
Edogawa-ku, Tokyo 133-0061, Japan
Edogawa-ku, Tokyo 134-0084, Japan
Meguro-ku, Tokyo 152-0031, Japan
Minato-ku, Tokyo 105-7390, Japan
Minato-ku, Tokyo 108-0075, Japan
Nerima-ku, Tokyo 177-0051, Japan
Shibuya-ku, Tokyo 150-0002, Japan
Shinagawa-ku, Tokyo 141-0032, Japan
Shinagawa-ku, Tokyo 142-0053, Japan
Shinagawa-ku, Tokyo 142-0063, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Toshima-ku, Tokyo 171-0021, Japan